Avapritinib
Avapritinib
The First Affiliated Hospital of Soochow UniversitySmall moleculePhase 1/2Active
CC
47/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 33/ 100
- Competitive Position
- 89/ 100
Competitive context
4 Active assets in the Avapritinib cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Cytosin-Arabinosid The First Affiliated Hospital of Soochow University | Phase 1/2 | CC |
Azacitidine The First Affiliated Hospital of Soochow University | Phase 1/2 | CC |
Venetoclax The First Affiliated Hospital of Soochow University | Phase 1/2 | CC |
Idarubicine The First Affiliated Hospital of Soochow University | Phase 1/2 | CC |
Same molecule, other indications
Avapritinib is also rated in:
systemic mastocytosis with an associated clonal hematologic non-mast cell lineage diseaseDormant
BB
Indicative ·
64 / 100
View asset →Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →